For safety with respect to transmissible agents, see Precautions.
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. To report SUSPECTED ADVERSE REACTIONS, contact Grifols at 1-323-225-2221.
View ADR Monitoring Form